πŸ‡ΊπŸ‡Έ FDA
Patent

US 9644004

Peptide and peptidomimetic inhibitors

granted A61KA61K38/00A61K38/10

Quick answer

US patent 9644004 (Peptide and peptidomimetic inhibitors) held by RA PHARMACEUTICALS, INC. expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RA PHARMACEUTICALS, INC.
Grant date
Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K38/10, A61K45/06, A61K47/60